Alzheimer's Disease
Showing NaN - NaN of 87
Alzheimer's Disease, Dementia Trial in Worldwide (Drug: EVP-6124, Placebo)
Terminated
- Alzheimer's Disease
- Dementia
- Drug: EVP-6124
- Placebo
-
Tucson, Arizona
- +80 more
May 2, 2016
Alzheimer's Disease, Dementia Trial in Worldwide (Drug: EVP-6124, Placebo)
Terminated
- Alzheimer's Disease
- Dementia
- Drug: EVP-6124
- Placebo
-
Phoenix, Arizona
- +81 more
May 2, 2016
Alzheimer's Disease Trial in Israel, United States (TMS and cognitive stimulation, sham)
Completed
- Alzheimer's Disease
- TMS and cognitive stimulation
- sham
-
Sun City, Arizona
- +9 more
Mar 29, 2016
Alzheimer's Disease Trial in United States (ACC-001 3 µg/ QS-21 50 µg, ACC-001 10 µg/ QS-21 50 µg, Placebo- Phosphate buffered
Completed
- Alzheimer's Disease
- ACC-001 3 μg/ QS-21 50 μg
- +2 more
-
Phoenix, Arizona
- +39 more
Jan 28, 2016
Alzheimer's Disease Trial in Worldwide (LY450139, Placebo)
Alzheimer's Disease Trial in United States (ACC-001 (vanutide cridificar))
Completed
- Alzheimer's Disease
- ACC-001 (vanutide cridificar)
-
Sun City, Arizona
- +24 more
Dec 11, 2014
Alzheimer's Disease Trial in Puerto Rico, United States (dl-alpha-tocopherol, Memantine, Placebo)
Alzheimer's Disease Trial in Worldwide (Bapineuzumab 0.5 mg/kg, Placebo Control, Bapineuzumab 1.0 m/kg)
Completed
- Alzheimer's Disease
- Bapineuzumab 0.5 mg/kg
- +2 more
-
Birmingham, Alabama
- +250 more
Oct 30, 2013
Alzheimer's Disease Trial in United States (Bapineuzumab 0.5 mg/kg, Placebo Control, Bapineuzumab 1.0 m/kg)
Completed
- Alzheimer's Disease
- Bapineuzumab 0.5 mg/kg
- +2 more
-
Birmingham, Alabama
- +185 more
Oct 30, 2013
Dementia, Alzheimer's Disease Trial in United States (Aripiprazole, Placebo)
Completed
- Dementia
- Alzheimer's Disease
- Aripiprazole
- Placebo
-
Santa Ana, California
- +13 more
Nov 7, 2013